These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12550109)

  • 1. Transforming growth factor-Beta 1 (tgf-Beta 1) in patients with amyotrophic lateral sclerosis.
    Iłzecka J; Stelmasiak Z; Dobosz B
    Cytokine; 2002 Dec; 20(5):239-43. PubMed ID: 12550109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma TGF-beta1 in patients with amyotrophic lateral sclerosis.
    Houi K; Kobayashi T; Kato S; Mochio S; Inoue K
    Acta Neurol Scand; 2002 Nov; 106(5):299-301. PubMed ID: 12371924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients.
    Iłzecka J
    Acta Neurol Scand; 2003 Aug; 108(2):125-9. PubMed ID: 12859290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis.
    Iłzecka J; Kocki T; Stelmasiak Z; Turski WA
    Acta Neurol Scand; 2003 Jun; 107(6):412-8. PubMed ID: 12757473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-β plasma levels and its role in amyotrophic lateral sclerosis.
    Duque T; Gromicho M; Pronto-Laborinho AC; de Carvalho M
    Med Hypotheses; 2020 Jun; 139():109632. PubMed ID: 32085981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis.
    Iłecka J
    J Neural Transm (Vienna); 2004 Feb; 111(2):167-72. PubMed ID: 14767719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin concentration in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Janik P; Kwiecinski H; Sokolowska B; Niebroj-Dobosz I
    J Neural Transm (Vienna); 2010 Mar; 117(3):343-7. PubMed ID: 20012656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-β1 in the cerebrospinal fluid of patients with distinct neurodegenerative diseases.
    Masuda T; Itoh J; Koide T; Tomidokoro Y; Takei Y; Ishii K; Tamaoka A
    J Clin Neurosci; 2017 Jan; 35():47-49. PubMed ID: 27756506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologically active TGF-beta 1 is increased in cerebrospinal fluid while it is reduced in serum in multiple sclerosis patients.
    Rollnik JD; Sindern E; Schweppe C; Malin JP
    Acta Neurol Scand; 1997 Aug; 96(2):101-5. PubMed ID: 9272186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid from patients with amyotrophic lateral sclerosis inhibits sonic hedgehog function.
    Drannik A; Martin J; Peterson R; Ma X; Jiang F; Turnbull J
    PLoS One; 2017; 12(2):e0171668. PubMed ID: 28170441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Dobosz B
    Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma amino acids concentration in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
    Amino Acids; 2003 Jul; 25(1):69-73. PubMed ID: 12836061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
    Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
    Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF levels in CSF and serum in mild ALS patients.
    Gao L; Zhou S; Cai H; Gong Z; Zang D
    J Neurol Sci; 2014 Nov; 346(1-2):216-20. PubMed ID: 25204587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum caspase-9 levels are increased in patients with amyotrophic lateral sclerosis.
    Iłżecka J
    Neurol Sci; 2012 Aug; 33(4):825-9. PubMed ID: 22048794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.